Brugada syndrome screening: Difference between revisions
| Line 11: | Line 11: | ||
OR | OR | ||
According to the [guideline name], screening for | According to the [guideline name], screening for Brugada syndrome is not recommended.<ref name="pmid30918662">{{cite journal |vauthors=Pappone C, Santinelli V |title=Brugada Syndrome: Progress in Diagnosis and Management |journal=Arrhythm Electrophysiol Rev |volume=8 |issue=1 |pages=13–18 |date=March 2019 |pmid=30918662 |pmc=6434501 |doi=10.15420/aer.2018.73.2 |url=}}</ref> | ||
OR | OR | ||
Revision as of 18:40, 25 November 2019
|
Brugada syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Brugada syndrome screening On the Web |
|
American Roentgen Ray Society Images of Brugada syndrome screening |
|
Risk calculators and risk factors for Brugada syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Relatives of patients with Brugada syndrome can be screened for the syndrome by obtaining an EKG, although the diagnostic pattern may be concealed. Genetic testing can also be used to support the diagnosis of Brugada syndrome and to detect relatives at risk.[1] Unfortunately, despite the association of the Brugada syndrome with the SCN5A genotype, there is unfortunately no association between the results of genetic testing and clinical prognosis.
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for Brugada syndrome is not recommended.[2]
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]
References
- ↑ Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A (2005). "Brugada syndrome: report of the second consensus conference". Heart Rhythm : the Official Journal of the Heart Rhythm Society. 2 (4): 429–40. PMID 15898165. Unknown parameter
|month=ignored (help);|access-date=requires|url=(help) - ↑ Pappone C, Santinelli V (March 2019). "Brugada Syndrome: Progress in Diagnosis and Management". Arrhythm Electrophysiol Rev. 8 (1): 13–18. doi:10.15420/aer.2018.73.2. PMC 6434501. PMID 30918662.